Navigation Links
VWR Funding, Inc. to Hold First Quarter 2008 Financial Results Conference Call
Date:5/7/2008

WEST CHESTER, Pa., May 7 /PRNewswire/ -- VWR Funding, Inc., the parent company of VWR International, LLC, a leading global laboratory supply company, will hold a conference call on Monday, May 19th to discuss its first quarter financial results.

Who: John M. Ballbach, Chairman, President and CEO

Jack L. Wyszomierski, Executive Vice-President & Chief Financial

Officer

When: Monday, May 19, 2008

9:00 a.m. Eastern Time (ET)

How: Interested parties may participate by dialing (877) 719-9801 (U.S.

and Canada) or 719-325-4785 (outside U.S. and Canada). A replay

of the call will be available from 12:00 p.m. ET on May 19, 2008

through midnight May 26, 2008 by dialing 888-203-1112 (U.S. and

Canada) or 719-457-0820 (outside U.S. and Canada), pass code for

both replay numbers: 4181472.

Information:

VWR Funding's Quarterly Report on Form 10-Q for the quarter ended March 31, 2008 will be filed on or before May 13, 2008 with the Securities and Exchange Commission.

About VWR International, LLC

VWR International is a leading global laboratory supply company with worldwide sales of $3.5 billion US dollars. VWR International's business is highly diversified across products and services, geographic regions and customer segments. The company offers products from a wide range of manufacturers to a large number of customers primarily in North America, Europe and Asia. VWR International's principal customers are major pharmaceutical, biotechnology, industrial and government organizations as well as universities and schools. VWR International distributes a diversified product mix, including chemicals, glassware and plasticware, equipment and instruments, furniture, protective apparel, production and safety products, and other life science and laboratory products and supplies. VWR International supports its customers by providing storeroom management, product procurement, supply chain systems integration, technical services, and laboratory bench top delivery. VWR International maintains operations in over 20 countries and employs over 6,500 people worldwide. VWR International is headquartered in West Chester, Pennsylvania.

For more information on VWR International, phone 1-800-932-5000, visit http://www.vwr.com, or write, VWR International, 1310 Goshen Parkway, P.O. Box 2656, West Chester, PA 19380-0906.
VWR and design are registered trademarks of VWR International, LLC

Contact: Robin Gervasoni

Phone: (610) 430-7258

Fax: (610) 719-7099

Email: robin_gervasoni@vwr.com


'/>"/>
SOURCE VWR Funding, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. VWR Funding, Inc. to Hold Fourth Quarter and Year-End 2007 Financial Results Conference Call
2. VWR Funding, Inc. to Hold Third Quarter 2007 Financial Results Conference Call
3. Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results
4. NeurogesX to Report First Quarter 2008 Financial Results
5. Oncothyreon Reports First Quarter 2008 Financial Results
6. Jazz Pharmaceuticals, Inc. to Announce First Quarter Results on May 13, 2008
7. iCAD Reports First Quarter 2008 Financial Results
8. SurgiQuest Announces First Single Port Procedure for Ovary Removal Using AirSeal(TM) Access System
9. AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
10. American Oriental Bioengineering Reports First Quarter 2008 Financial Results
11. Advanced Life Sciences Announces First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) ... of the Class of 2016 were selected from a pool of 128 applicants ... the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... Durham, NC (PRWEB) , ... June 23, 2016 , ... ... Odense University Hospital in Denmark detail how a patient who developed lymphedema after being ... (fat) tissue. The results could change the paradigm for dealing with this debilitating, frequent ...
Breaking Biology Technology:
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):